Does prophylactic treatment with pravastatin reduce the risk of developing pre-eclampsia?
Prophylactic pravastatin may reduce the risk of pre-eclampsia and adverse neonatal outcomes.
Prophylactic treatment with pravastatin appears to reduce risk of developing pre-eclampsia as well as potentially lowering risk of IUGR, preterm birth, and NICU admission in neonates.
Mészáros et al. (Fri,) studied this question.